Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model-Reference-Cited by-同舟云学术

Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model

Published:2016-10 Issue:2 Volume:381 Page:296-304
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Weber Tobias,Bötticher Benedikt,Arndt Michaela A.E.,Mier Walter,Sauter Max,Exner Evelyn,Keller Armin,Krämer Susanne,Leotta Karin,Wischnjow Artjom,Grosse-Hovest Ludger,Strumberg Dirk,Jäger Dirk,Gröne Hermann-Josef,Haberkorn Uwe,Brem Gottfried,Krauss Jürgen

Funder

Deutsche José Carreras Leukämie-Stiftung

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Antibody-targeted radiation cancer therapy;Milenic;Nat. Rev. Drug Discov,2004

2. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma;Witzig;J. Clin. Oncol,2002

3. Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma;Witzig;J. Clin. Oncol,2002

4. Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I;Stein;J. Nucl. Med,2001

5. 177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo;Michel;Nucl. Med. Biol,2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carrier systems of radiopharmaceuticals and the application in cancer therapy;Cell Death Discovery;2024-01-09

2. Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma;International Reviews of Immunology;2019-03-04